Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osheroff

Showing results (271-280 of 362) with videos related to

Pageof 37
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1984
A species of human alpha interferon that lacks the ability to boost human natural killer activityJ R Ortaldo, R B Herberman, C Harvey, et al.
Biochemistry|July 15, 2017
Interactions between Quinolones and Bacillus anthracis Gyrase and the Basis of Drug ResistanceRachel E Ashley, R Hunter Lindsey, Sylvia A McPherson, et al.
The Journal of Biological Chemistry|May 8, 2003
The base substitution fidelity of DNA polymerase beta-dependent single nucleotide base excision repairToshiro Matsuda, Brian J Vande Berg, Katarzyna Bebenek, et al.
Antimicrobial Agents and Chemotherapy|September 24, 2014
Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridgeKatie J Aldred, Erin J Breland, Sylvia A McPherson, et al.
The Journal of Biological Chemistry|May 25, 1983
Preferred sites for electron transfer between cytochrome c and iron and cobalt complexesJ Butler, S K Chapman, D M Davies, et al.
ACS Infectious Diseases|October 9, 2025
Mechanism of Action of Gepotidacin: Well-Balanced Dual-Targeting against <i>Neisseria gonorrhoeae</i> Gyrase and Topoisomerase IV in Cells and In VitroAlexandria A Oviatt, Jessica A Collins, Chelsea A Mann, et al.
ACS Infectious Diseases|April 12, 2024
Interactions between Gepotidacin and <i>Escherichia coli</i> Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-TargetingAlexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, et al.
Inorganic Chemistry|October 27, 2010
First ruthenium organometallic complex of antibacterial agent ofloxacin. Crystal structure and interactions with DNAIztok Turel, Jakob Kljun, Franc Perdih, et al.
Biochemistry|September 25, 2002
Site-specific DNA cleavage by Chlorella virus topoisomerase IIJohn M Fortune, Jennifer S Dickey, Oleg V Lavrukhin, et al.
The Journal of Biological Chemistry|April 27, 2001
Topoisomerase II from Chlorella virus PBCV-1 has an exceptionally high DNA cleavage activityJ M Fortune, O V Lavrukhin, J R Gurnon, et al.
Pageof 37

Showing results (271-280 of 362) with videos related to

Sort By:
Pageof 37
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1984
A species of human alpha interferon that lacks the ability to boost human natural killer activityJ R Ortaldo, R B Herberman, C Harvey, et al.
Biochemistry|July 15, 2017
Interactions between Quinolones and Bacillus anthracis Gyrase and the Basis of Drug ResistanceRachel E Ashley, R Hunter Lindsey, Sylvia A McPherson, et al.
The Journal of Biological Chemistry|May 8, 2003
The base substitution fidelity of DNA polymerase beta-dependent single nucleotide base excision repairToshiro Matsuda, Brian J Vande Berg, Katarzyna Bebenek, et al.
Antimicrobial Agents and Chemotherapy|September 24, 2014
Bacillus anthracis GrlAV96A topoisomerase IV, a quinolone resistance mutation that does not affect the water-metal ion bridgeKatie J Aldred, Erin J Breland, Sylvia A McPherson, et al.
The Journal of Biological Chemistry|May 25, 1983
Preferred sites for electron transfer between cytochrome c and iron and cobalt complexesJ Butler, S K Chapman, D M Davies, et al.
ACS Infectious Diseases|October 9, 2025
Mechanism of Action of Gepotidacin: Well-Balanced Dual-Targeting against <i>Neisseria gonorrhoeae</i> Gyrase and Topoisomerase IV in Cells and In VitroAlexandria A Oviatt, Jessica A Collins, Chelsea A Mann, et al.
ACS Infectious Diseases|April 12, 2024
Interactions between Gepotidacin and <i>Escherichia coli</i> Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-TargetingAlexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, et al.
Inorganic Chemistry|October 27, 2010
First ruthenium organometallic complex of antibacterial agent ofloxacin. Crystal structure and interactions with DNAIztok Turel, Jakob Kljun, Franc Perdih, et al.
Biochemistry|September 25, 2002
Site-specific DNA cleavage by Chlorella virus topoisomerase IIJohn M Fortune, Jennifer S Dickey, Oleg V Lavrukhin, et al.
The Journal of Biological Chemistry|April 27, 2001
Topoisomerase II from Chlorella virus PBCV-1 has an exceptionally high DNA cleavage activityJ M Fortune, O V Lavrukhin, J R Gurnon, et al.
Pageof 37